NCT07565519 Effects of a Multicomponent Exercise Program in Older Adults Undergoing Cancer Treatment: A Randomized Controlled Trial
| NCT ID | NCT07565519 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Federal University of Rio Grande do Sul |
| Condition | Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 180 participants |
| Start Date | 2026-03-02 |
| Primary Completion | 2027-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 180 participants in total. It began in 2026-03-02 with a primary completion date of 2027-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to understand how a home-based exercise program can help improve strength, mobility, and quality of life in older adults receiving cancer treatment. Participants will be randomly divided into two groups: One group will follow a one-year multicomponent exercise program based on the ViviFrail model, done safely at home. The other group will continue with usual care. We will include men and women aged 60 or older treated at Hospital Conceição in Porto Alegre. Assessments will take place at the beginning and after 12, 24, and 48 weeks. We will measure walking speed, balance, muscle strength, and ask about quality of life, symptoms, and daily activity. The goal is to see whether home-based exercise can help older adults with cancer stay stronger, more independent, and feel better during treatment.
Eligibility Criteria
Inclusion Criteria: Men and women aged 60 years or older who are undergoing cancer treatment at Hospital Conceição in Porto Alegre, who have the cognitive ability to understand the exercises, are able to walk (even with assistance), and have medical clearance to participate in physical exercise will be included in the study. \- Exclusion Criteria: Participants who miss more than two assessments will be excluded. \-
Contact & Investigator
Eduardo L Cadore, PhD
PRINCIPAL INVESTIGATOR
Federal University of Rio Grande do Sul
Frequently Asked Questions
Who can join the NCT07565519 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07565519 currently recruiting?
Yes, NCT07565519 is actively recruiting participants. Contact the research team at edcadore@yahoo.com.br for enrollment information.
Where is the NCT07565519 trial being conducted?
This trial is being conducted at Porto Alegre, Brazil, Porto Alegre, Brazil.
Who is sponsoring the NCT07565519 clinical trial?
NCT07565519 is sponsored by Federal University of Rio Grande do Sul. The principal investigator is Eduardo L Cadore, PhD at Federal University of Rio Grande do Sul. The trial plans to enroll 180 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.